Search
for

    Sort by

    Research 631–660 of 1000+

    1. Does zinc have a role in alopecia areata? A clinic-biochemical study Global journal of health sciences and research · 2023
    2. Overview of the Role of 308 Monochromatic Excimer Phototherapy for the Treatment of Alopecia Areata IntechOpen eBooks · 2022
    3. THE EFFECT OF AUTOLOGOUS PLATELET RICH PLASMA (PRP) ON PATIENTS WITH ALOPECIA AREATA ˜Al-œAzhar Medical Journal · 2017
    4. The diagnosis and management of alopecia South African Family Practice · 2012
    5. Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition Nature medicine · 2014 · 701 citations
    6. A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results Journal of the American Academy of Dermatology · 2021 · 138 citations
    7. Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata Journal of the American Academy of Dermatology · 2017 · 83 citations
    8. Alopecia areata: a new treatment plan Clinical, cosmetic and investigational dermatology · 2011 · 67 citations
    9. An integrated model of alopecia areata biomarkers highlights both TH1 and TH2 upregulation Journal of Allergy and Clinical Immunology · 2018 · 58 citations
    10. Immunological Properties of Atopic Dermatitis-Associated Alopecia Areata International Journal of Molecular Sciences · 2021 · 57 citations
    11. Endogenous Retinoids in the Pathogenesis of Alopecia Areata 2012 · 54 citations
    12. Alopecia Areata: Treatment of Today and Tomorrow Journal of Investigative Dermatology Symposium Proceedings · 2003 · 48 citations
    13. High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata JCI insight · 2018 · 46 citations
    14. Major Histocompatibility Complex Class I Chain-Related Gene A Polymorphisms and Extended Haplotypes Are Associated with Familial Alopecia Areata Journal of Investigative Dermatology · 2005 · 44 citations
    15. A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata Archives of dermatological research · 2018 · 42 citations
    16. Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis JAMA Dermatology · 2015 · 41 citations
    17. The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications Cells · 2021 · 37 citations
    18. Race and Alopecia Areata amongst US Women Journal of Investigative Dermatology Symposium Proceedings · 2017 · 37 citations
    19. Human Leukocyte Antigen Class II Alleles Are Associated with Risk of Alopecia Areata Journal of Investigative Dermatology · 2007 · 36 citations
    20. Screening Guidelines for Thyroid Function in Children With Alopecia Areata JAMA dermatology · 2017 · 35 citations
    21. Alopecia areata and risk of atopic and autoimmune conditions: population-based cohort study Clinical and Experimental Dermatology · 2022 · 34 citations
    22. Recombinant human hepatitis B vaccine initiating alopecia areata: testing the hypothesis using the C3H/HeJ mouse model Veterinary Dermatology · 2009 · 23 citations
    23. Predictive Metagenomic Profiling, Urine Metabolomics, and Human Marker Gene Expression as an Integrated Approach to Study Alopecia Areata Frontiers in Cellular and Infection Microbiology · 2020 · 22 citations
    24. Association Between Interleukin 18 Polymorphisms and Alopecia Areata in Koreans Journal of Interferon & Cytokine Research · 2014 · 22 citations
    25. Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience Journal of Dermatological Treatment · 2023 · 21 citations
    26. Phenotypic Analysis of T-Cells in Extensive Alopecia Areata Scalp Suggests Partial Tolerance 2005 · 21 citations
    27. Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2) American Journal of Clinical Dermatology · 2023 · 20 citations
    28. Chronic delayed-type hypersensitivity reaction as a means to treat alopecia areata Clinical & Experimental Immunology · 2004 · 20 citations
    29. Dupilumab therapy for alopecia areata in pediatric patients with concomitant atopic dermatitis Journal of the American Academy of Dermatology · 2021 · 19 citations
    30. Alopecia areata susceptibility variant in MHC region impacts expressions of genes contributing to hair keratinization and is involved in hair loss EBioMedicine · 2020 · 19 citations